Corrigendum to “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB”
Joint Authors
Shu, Yilai
Chen, Jian
Wu, Haitao
Zhang, Linlin
Chen, Liping
Zhu, Min
Yao, Song
Wang, Jiabing
Wu, Jianzhang
Liang, Guang
Li, Wulan
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-12-28
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB” [1], the cell line HEp-2 used in the study had been reported to be contaminated by HeLa, a cervical cancer cell line.
Therefore, the study can only prove that the compound CA15 has antitumor effects, not antihuman laryngeal carcinoma.
American Psychological Association (APA)
Chen, Jian& Zhang, Linlin& Shu, Yilai& Chen, Liping& Zhu, Min& Yao, Song…[et al.]. 2017. Corrigendum to “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB”. BioMed Research International،Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1135851
Modern Language Association (MLA)
Chen, Jian…[et al.]. Corrigendum to “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB”. BioMed Research International No. 2017 (2017), pp.1-1.
https://search.emarefa.net/detail/BIM-1135851
American Medical Association (AMA)
Chen, Jian& Zhang, Linlin& Shu, Yilai& Chen, Liping& Zhu, Min& Yao, Song…[et al.]. Corrigendum to “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB”. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1135851
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1135851
